Related Experiment Videos
Problems with the laboratory identification and evaluation of coagulase-negative staphylococci
Pathology
|January 1, 1986
Summary
Coagulase-negative staphylococci, particularly Staphylococcus epidermidis, are common in clinical specimens and show significant antibiotic resistance. Methicillin resistance was noted in S. saprophyticus group strains, with gentamicin resistance linked to significant isolates from catheter tips and blood cultures.
Area of Science:
- Medical Microbiology
- Clinical Diagnostics
- Infectious Diseases
Background:
- Coagulase-negative staphylococci (CoNS) are frequently isolated from clinical specimens.
- Understanding the prevalence and significance of different CoNS species is crucial for patient care.
Purpose of the Study:
- To identify and characterize CoNS isolates from routine clinical specimens.
- To assess the pathological significance and antibiotic resistance patterns of these CoNS.
Main Methods:
- Prospective recovery of 796 CoNS isolates over 105 days from various specimen types.
- Presumptive identification of 315 isolates, including Staphylococcus epidermidis, S. capitis, and S. saprophyticus group.
- Assessment of pathological significance using laboratory criteria and analysis of antibiograms.
Main Results:
- Staphylococcus epidermidis was the most common species (55.6%).
- Significant proportions of CoNS from catheter tips (44.8%), urines (25.9%), and blood cultures (4.5%) were deemed potentially significant.
- High rates of antibiotic resistance were observed, including penicillin (63.2%), methicillin (22.6%), and gentamicin (27.5%), with multiple resistance being common.
- Methicillin resistance was prevalent in S. saprophyticus group strains.
Conclusions:
- CoNS are prevalent in clinical settings, with S. epidermidis being the most common.
- A notable percentage of CoNS isolates, especially from invasive sites, are potentially pathogenic.
- Widespread antibiotic resistance, including methicillin and gentamicin resistance, poses a significant challenge in managing CoNS infections.